Mineralys Therapeutics ($MLYS) Insider Trading & Smart Money Activity
Mineralys Therapeutics, Inc. ($MLYS) has 14 insider trades on file. In the last 12 months on the open market, no insider bought and 6 insiders sold ($7.27M), net -$7.27M.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 6
- Net insider $ (12 mo)
- -$7.27M
- Congress trades (12 mo)
- 0
- 13F moves on file
- 0
- Analyst ratings on file
- 0
MLYS insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 3 · $2.15M | 0 / 0 | 0 / 0 |
| Q3 2026 | 0 | 3 · $5.12M | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All MLYS insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Congleton JonChief Executive Officer | Sell (Open-market sale) 10b5-1 | 75K sh | $1.91M | -12.1% | — | |||||
| Insider | Slingsby Brian TaylorDirector | Sell (Open-market sale) | 104.32K sh | $3.01M | -16.7% | — | |||||
| Insider | Warren EricChief Commercial Officer | Sell (Open-market sale) 10b5-1 | 7.44K sh | $209.14K | -9.5% | — | |||||
| Insider | Jon CongletonChief Executive Officer | Sell (Open-market sale) 10b5-1 | 75K sh | $1.96M | +12.9% | -2.9% | Read | ||||
| Insider | Eric WarrenChief Commercial Officer | Sell (Option exercise) | 104.12K sh | +9.1% | +2.0% | Read | |||||
| Insider | Eric WarrenChief Commercial Officer | Buy (Option exercise) | 104.12K sh | $1.38M | +9.1% | +2.0% | Read | ||||
| Insider | Rodman David MalcomChief Medical Officer | Sell (Open-market sale) 10b5-1 | 4.58K sh | $114.60K | +2.5% | +7.8% | Read | ||||
| Insider | Rodman David MalcomChief Medical Officer | Buy (Option exercise) | 4.58K sh | $65.82K | +2.5% | +7.8% | Read | ||||
| Insider | Daphne Karydas | Sell (Open-market sale) 10b5-1 | 3K sh | $75K | +2.5% | +7.8% | Read | ||||
| Insider | Daphne Karydas | Buy (Option exercise) | 3K sh | $36.06K | +2.5% | +7.8% | Read | ||||
| Insider | Rodman David MalcomChief Medical Officer | Sell (Option exercise) | 6.35K sh | +7.4% | +16.8% | — | |||||
| Insider | Rodman David MalcomChief Medical Officer | Sell (Option exercise) | 6.35K sh | +7.4% | +16.8% | — | |||||
| Insider | Rodman David MalcomChief Medical Officer | Buy (Option exercise) | 6.35K sh | $6.86K | +7.4% | +16.8% | — | ||||
| Insider | Rodman David MalcomChief Medical Officer | Buy (Option exercise) | 6.35K sh | $6.86K | +7.4% | +16.8% | — |
1W / 1M / 6M = how MLYS moved from the trade or filing date.
Insider trading in MLYS: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Congleton Jon | Chief Executive Officer | 1 | -$1.91M | Sep 30, 2026 | |
| Slingsby Brian Taylor | Director | 1 | -$3.01M | Sep 22, 2026 | |
| Warren Eric | Chief Commercial Officer | 1 | -$209.14K | Sep 21, 2026 | |
| Jon Congleton | Chief Executive Officer | 1 | -$1.96M | Jun 30, 2026 | |
| Eric Warren | Chief Commercial Officer | 2 | — | Jun 26, 2026 | |
| Rodman David Malcom | Chief Medical Officer | 6 | -$114.60K | Jun 17, 2026 | |
| Daphne Karydas | 2 | -$75K | Jun 17, 2026 |
Frequently asked questions
Are MLYS insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 6 insiders made 6 open-market sales worth $7.27M, a net -$7.27M.
What is the latest insider trade in MLYS?
Congleton Jon, Chief Executive Officer filed a sell (open-market sale) of 75K sh worth $1.91M on Sep 30, 2026.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.